Latest Earnings Results: Q3 '26
Estimated EPS
-$0.26
Reported EPS
-$0.19
Surprise
+25.96%
Estimated Rev
$21.93M
Reported Rev
$22.83M
Surprise
+4.11%
• Reported GAAP EPS of -$0.19 up 44.12% YoY • Reported revenue of $22.84M up 6.23% YoY • Pulmonx expects full-year 2026 revenue of $90M to $92M, gross margin of approximately 77%, and total operating expenses of $108M to $109M, including approximately $14M of non-cash stock-based compensation.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.22 | -- | -- | N/A |
Q3 '26 | -$0.26 | -$0.19 | 25.96% | BEAT |
Q2 '26 | -$0.25 | -$0.24 | 4.00% | BEAT |
Q1 '26 | -$0.33 | -$0.33 | -1.02% | MISSED |
Q4 '25 | -$0.38 | -$0.25 | 35.06% | BEAT |